23 September 2019 – We Company IPO Issues Ongoing + Telecoms Sector Webinar

Big Ones

We have a lot of IPO news for you this week but let’s talk about We Company for a moment, because no other company has had quite as tough a time of trying to go public (not even Uber’s failure to reach the IPO price for weeks after going public comes close). Really, We Co hasn’t found the path to its IPO very much fun but arguably even more eyes have been focused on its largest investor, SoftBank. The IPO may have been delayed until… sometime later this year after rumours that the offering could be cancelled altogether. Sources have told the Wall Street Journal that SoftBank is set to buy up $750m of shares in an IPO that will raise about $3bn when (if!) it eventually happens. The bigger shock has of course been news that We Company’s valuation is set to tumble from $47bn in January to between $15bn and $20bn when it floats.

The ongoing issues with the We Company IPO appear to be hitting SoftBank in other areas, too. The corporate is still in the process of finalising LP commitments for its second Vision Fund, but sovereign wealth funds PIF and Mubadala are reportedly pulling back their exposure having supplied a total of $60bn for the first fund. Taking big bets, as Masayoshi Son is prone to do, after all can also mean you might end up losing big.

Automattic is valued at just (just!) $3bn despite claiming to power around one third of the world’s websites, having received $300m in series D funding from Salesforce Ventures. The company is likely doing okay financially too, considering it last raised money five years ago, in a $160m series C round that valued it at $1bn pre-money and it’s fresh off a purchase of reportedly less than $3m acquisition of Tumblr, the blogging platform that Yahoo purchased for $1.1bn in 2013, before Yahoo was acquired by Verizon, Verizon banned any sexual content in December 2018 and user numbers crashed.

In a fascinating GCV-GUV crossover, robotic surgery technology developer CMR Surgical has secured $240m in series C funding at a reported valuation of about $1.2bn. The company, whose earlier backers include ABB Technology Ventures, raised the cash from investors including Cambridge Innovation Capital, LGT, Watrium, Zhejiang Silk Road Fund and Escala Capital.

Deals

GitLab has completed a $268m series E round co-led by Goldman Sachs that valued the software development and management platform at $2.75bn. The company, whose investors also include Alphabet unit GV, is aiming for a November 2020 IPO and will channel the series E proceeds into hiring and product development.

Online payment technology provider Stripe is now one of the few VC-backed private companies to have outdone that valuation, having secured $250m in funding at an eye watering $35bn pre-money valuation.

DataRobot is meanwhile also valued at $1.2bn, having confirmed a $206m series E round that included Intel Capital. Reports in July had suggested the enterprise AI technology provider was raising $200m, and the round boosted its overall funding to more than $430m.

Self-driving truck developer TuSimple has raised $120m from investors including Mando and UPS Ventures for a series D round that now totals $215m. The overall round is being led by another corporate, Sina, and the capital will go to expanding the range of TuSimple’s fleet and the further co-development of an autonomous truck for commercial use.

Funds

Data analysis software producer Splunk has been a relatively low-profile figure in the corporate venturing space but expect that to pick up following its formation of a unit called Splunk Ventures that will be equipped with $150m of capital.

On GUV, Italy-based venture capital firm Eureka! Venture has launched a €50m ($55m) fund with an initial close of $33m thanks to a commitment by investment platform ItaTech. The Eureka! Fund I – Technology Transfer will focus on the commercialisation of deeptech and has partnered a total of 19 universities and research institutes across the country, though only Polytechnic University of Turin and Istituto Italiano di Tecnologia’s Technology Transfer office were named.

Exits

A lot of huge startups have gone public this year but it’s been a mixed bag in terms of outcomes. Airbnb is one of the few decacorns ($10bn+ valuations) still to make the jump in the US, but has now said it plans to list its shares publicly in 2020.

Cloud hosting services provider CloudFlare has secured $525m in its IPO, floating above a range that it had already increased last week. Its investors include Microsoft, Baidu, CapitalG and Qualcomm Ventures, and the company’s stock closed at $18.00 on its first day of trading on Friday.

Henlius, a developer of biosimilar treatments for cancer and autoimmune disorders, has priced its shares for an initial public offering that will net the company $410m when it floats in Hong Kong next week. Fosun Pharma is the largest investor in Henlius, which was valued at $3bn when it last raised funding, in July 2018.

IGM Biosciences has secured $175m in its own IPO, floating at the midpoint of its range before seeing its shares shoot up some 50% in their first day of trading yesterday. The company, which is developing antibodies to treat cancer, counts Haldor Topsøe as its largest shareholder, though the corporate’s stake was diluted from a majority share to 39% in the offering. IGM’s market cap is around the $700m mark at time of writing.

Pfizer spinoff SpringWorks Therapeutics has raised $162m after floating at the top of its range. The rare disease and cancer therapy developer had collected $228m in funding across two rounds, from investors that also included GlaxoSmithKline, and its shares are trading around 30% higher than its IPO price at the time of writing.

SoftBank has at least done very well out of the IPO of one of its portfolio companies. Cancer test developer Guardant Health’s shares were priced at $19 each when it floated last October but SoftBank has just sold 4.9 million shares at $77 a pop to raise a total of $377m. That’s a huge return but it also comes after Guardant’s shares fell from a peak of about $110 last month. SoftBank remains the company’s largest shareholder.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

26 August 2019 – Uhuru Plans to File for an IPO

Exits

Uhuru to connect to UK’s public markets

Pfizer spinoff Springworks is developing drug treatments for rare forms of cancer, and has filed to raise up to $115m in an initial public offering that would also allow GlaxoSmithKline to exit.

Medical research tool developer 10x Genomics has already reached unicorn status, having closed a SoftBank-backed series D round that valued it at almost $1.3bn earlier this year. Business is going well for 10x, which more than doubled its revenue in 2018, and which has now filed for a $100m initial public offering.

IGM Biosciences has filed for its own $100m IPO – it’s been quite a few days for IPO filings – and the company, which is developing engineered antibodies that will treat cancer, is launching the offering just weeks after it secured $102m in series C funding.

Satsuma sets course for public markets

TSE gives Giftee IPO permission

University

VMware ingrains StartX-backed Intrinsic

Woodford loses touch with Ultrahaptics

Funds

SoftBank is reportedly offering to lend its employees up to $20bn to invest in the second iteration of its Vision Fund, reportedly replicating a process in which staff borrowed $8bn to invest in its predecessor.

Access Ventures accepts corporate backing

Deals

Microfinance provider Tala is reportedly now valued at $750m following a $110m series D round that included existing backer PayPal. The cash will fund international recruitment and an expansion of the company’s product range, and it comes after Tala had received some $100m in debt financing over the past year.

Lixiang, the Chinese electric SUV developer formerly known as Chehejia and CHJ Automotive, has closed its series C round at $530m at a $2.9bn valuation, with, $30m coming from new corporate backer Bytedance.

WeWork (now We Company) is gearing up for one of the year’s biggest IPOs but it isn’t the only company in the working space sector that’s growing quickly. Knotel has secured $400m from investors including Mori Trust, Itochu, Bloomberg Beta and Rocket Internet to increase its total funding to $560m.

Electronic cigarette maker Juul raised a gargantuan $12.8bn from cigarette manufacturer Altria last December at a $38bn valuation, but it isn’t done yet. The company has added$325m in convertible note financing from four investors according to a securities filing, and the cash will likely support an increasingly widespread advertising campaign as it looks to geographically expand.

PlusAI is one of a few autonomous vehicle developers currently in the pre-production stage, but is focusing its efforts on a truck with level 2 autonomous driving functionality that it hopes to be able to mass produce. It is also reportedly near to raising $200m at a valuation exceeding $1bn.

Mortgage financier Better.com is now valued at $600m, following its completion of a $120m series C round. Ping An Global Voyager Fund and American Express Ventures both contributed, as did Citi, Ally Financial, AGNC and Goldman Sachs, and the transaction took Better’s overall funding past the $250m mark.

Once upon a time, when it was a credible threat to Flipkart, Snapdeal’s largest investor was SoftBank. Then, when sales went south the corporate withdrew its support from a funding round in order to try and trigger a merger between the two – both among its portfolio companies. That deal didn’t come off, Walmart acquired SoftBank’s stake in Flipkart, and Snapdeal radically restructured and improbably survived. Now, SoftBank is in talks to lead a $100m round for the company, potentially with an investment of up to $60m. A case of forgive and forget?

Naspers to gamble on $100m Dream11 investment

University

XpectVision meets series B expectations


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0